February 26, 2019 - Gestalt Diagnostics Announces Advisory Board Formation with Leading Industry Experts
February 4, 2019 - Gestalt Diagnostics Expands Market Reach and Solution Offerings with Peak Medical Acquisition
Nov 27, 2018 - PathologyWatch Chooses Gestalt Diagnostics’ Digital Pathology Solution
November 14, 2018 - Gestalt’s COO & CSO publishes article on POCT in Medical Laboratory Observer, November issue
November 14, 2018 - Lisa-Jean Clifford, Gestalt’s COO & CSO featured in the Executive Spotlight for Medical Laboratory Observer, November issue
October 22, 2018 - Gestalt Diagnostics to Participate in Digital Pathology Connectathon
October 16, 2018 - Industry Veteran, Dr. David Hoak Joins Gestalt Diagnostics as Medical Director, Board Member
August 23, 2018 - Gestalt Diagnostics Named Top 10 Oncology Solution Provider
August, 2018 - Gestalt Diagnostics Expands Executive Team
FutureLab 2018 – October 24 7:30 – 3:30, Washington D.C. Lisa-Jean Clifford, Gestalt’s COO & Chief Strategy Officer
to participate in expert panel.
Lab Institute 2018 – October 24-26, Washington D.C. Lisa-Jean Clifford, Gestalt COO & Chief Strategy Officer to
Present session during the Critical Trends and Disrupters track, “Accelerating Diagnosis and Treatment of Cancer Using Digital Pathology”, on October 25 at 1:15.
Pathology Visions 2018 – November 4-6, San Diego, CA. Gestalt will be exhibiting in booth #107
API Digital Pathology and AI Summit – December 7, Columbus, OH. Gestalt is a sponsor and exhibitor.